Gingko bioworks stock.
1,292. Jason Kelly. https://www.ginkgobioworks.com. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.
Ginkgo Bioworks. Market Cap. $3B. Today's Change. (1.59%) $0.02. Current Price. $1.28. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing ...2. Ginkgo Bioworks. Ginkgo Bioworks has scaled up the process of engineering organisms that can be used in a variety of industries, from agriculture to …Ginkgo Bioworks Follow Share $0.12 Dec 1, 4:15:01 PM GMT-5 · USD · NYSE · Disclaimer search Compare to In the news The Motley Fool 30 minutes ago If You Invested $1,000 …Nov 9, 2023 · For its third quarter, Ginkgo's revenue fell by 17% year over year to $55 million. The company said an expected decline in schools dampened sales in its biosecurity business segment. An ... Ginkgo Bioworks SPAC IPO. The transaction values Ginkgo Bioworks at $15 billion. The deal is expected to provide up to $2.5 billion in cash proceeds. This includes $1.725 billion from Soaring Eagle’s trust and $775 million from a private investment in public equity (PIPE). The PIPE prices shares of Ginkgo Bioworks stock at $10.
Oct 6, 2021 · In about an hour following the publication of Scorpion’s 175-page report, Ginkgo’s stock price dropped at least 20%, down to about $9.50 a share. Synthetic biology pioneer Ginkgo Bioworks agreed to go public today in a $17.5 billion SPAC deal. The Boston-based company will merge with Soaring Eagle Acquisition Corp., a blank-check firm ...Nov 21, 2023 · Ginkgo Bioworks Holdings Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Ginkgo Bioworks Holdings Inc’s trailing 12-month revenue is $315.0 million with a -272.3% profit margin. Year-over-year quarterly sales growth most recently was -16.6%.
Ginkgo Bioworks stock plunged as much as 24% on Wednesday after a short-seller report from Scorpion Capital alleged that the synthetic biology company is a "Frankenstein mash-up of the worst frauds."
Which executives are buying and selling shares of Ginkgo Bioworks stock? View the latest DNA insider trading activity at MarketBeat. Skip to main content. S&P 500 4,594.63. DOW 36,245.50. QQQ 389.94. 15 best consumer discretionary stocks for the rest of …Dec 1, 2023 · Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($0.37) to ($0.30) per share. Ginkgo Bioworks has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates. Read More. Nov 27, 2023 · Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. [Read more] In 2022, DNA's revenue was $477.71 million, an increase of 52.21% compared to the previous year's $313.84 million. Losses were -$2.10 billion, 15.0% more than in 2021. A high-level overview of Ginkgo Bioworks Holdings, Inc. (DNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
#Synbio darling Ginkgo Bioworks $DNA released their 2022 results along with a 10-K filing. We perused all their year-end collateral for insights, starting wi...
Shares of Ginkgo Bioworks ( NYSE: DNA) added ~10% pre-market Tuesday after the cell platform company and Google Cloud, a unit of tech giant Alphabet Inc. ( NASDAQ: GOOG) ( NASDAQ: GOOGL ...
Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. [Read more] In 2022, DNA's revenue was $477.71 million, an increase of 52.21% compared to the previous year's $313.84 million. Losses were -$2.10 billion, 15.0% more than in 2021.The honeymoon for newly minted Ginkgo Bioworks (DNA-2.16%) shares recently came to an abrupt end, and it didn't take long. The synthetic-biology start-up just made its stock market debut in mid ...Find the latest Ginkgo Bioworks Holdings, Inc. (DNA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.“Ginkgo Bioworks does not deserve to use the DNA ticker,” said Stat stock reporter Adam Feuerstein. SPACs are a Wall Street trend that offers an IPO path with a little less than the usual ...Ginkgo Bioworks Holdings Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 29, 2023 7:59 p.m. EST Delayed quote $ 1.4200 0.03 2.16% After Hours Volume: 270.43K Advanced...
23 de ago. de 2021 ... Ginkgo Bioworks is an exceptional company leading the revolution in Synthetic Biology. They have product market fit, are delivering HYPER ...Detailed statistics for Ginkgo Bioworks Holdings, Inc. (DNA) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Ginkgo Bioworks Holdings, Inc. (DNA) stock, including valuation metrics, financial numbers, share information and more. ... The stock price has decreased by …Key Insights. Significantly high institutional ownership implies Ginkgo Bioworks Holdings' stock price is sensitive to their trading actions. A total of 7 investors have a majority stake in the ...Ginkgo Bioworks Holdings, Inc. (DNA Quick Quote DNA - Free Report) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.30.This compares to loss of ...See the company profile for Ginkgo Bioworks Holdings, Inc. (DNA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...
Ginkgo Bioworks (NYSE:DNA) Is among the more prominent stocks in the synthetic biology space. The company is located in Boston, Massachusetts, which is a …The highly mechanized lab — operated by Ginkgo Bioworks, a fast-growing start-up in Boston — is an engine room of synthetic biology, an emerging field that applies the tools of engineering and ...
Detailed statistics for Ginkgo Bioworks Holdings, Inc. (DNA) stock, including valuation metrics, financial numbers, share information and more. Detailed statistics for Ginkgo Bioworks Holdings, Inc. ... Ginkgo Bioworks Holdings, Inc. (DNA) NYSE: DNA · IEX Real-Time Price · USD. Add to Watchlist 1.46 +0.08 (5.80%)Is Ginkgo Bioworks a stock worth buying? When the stock began trading in September 2021, its valuation was around $15 billion. Today, it has a market capitalization of just $3.2 billion.Ginkgo Bioworks Holdings Inc (DNA) Sell: $1.45 Buy: $1.46 $0.08 (5.80%) Market closed | Prices as at close on 24 November 2023 | Turn on streaming prices. Add to watchlist. This stock can be held ...1. Ginkgo Bioworks. Ginkgo Bioworks is a biotech company that went public through a special purpose acquisition company last year. The company has the backing of Bill Gates and can design and ...Ginkgo Bioworks Holdings, Inc. ( NYSE:DNA) shareholders that were waiting for something to happen have been dealt a blow with a 30% share price drop in …First quarter 2023 Total revenue of $81 million, down from $168 million in the comparable prior year period, a decrease of 52% driven by the expected ramp down of K-12 testing in Ginkgo's ...
1. Ginkgo Bioworks. Ginkgo Bioworks ( DNA) saw its shares fall by 69% over the last 12 months, but that could be just the opening that value-hunting investors need to start a position. Unlike ...
Ginkgo Bioworks originally told investors to expect full-year 2022 revenue of at least $160 million from the biosecurity unit. That was increased to at least $210 million in May and increased to ...
In connection with the Closing, the Company will change its name to Ginkgo Bioworks Holdings, Inc. and the combined company’s shares of Class A common stock and public warrants are expected to ...Those are some eye-opening estimates, particularly since the leader in synthetic biomanufacturing, Ginkgo Bioworks (DNA 2.16%), currently has a market cap of $6 billion and trades for a little ...Wood keeps buying DNA stock despite it being down more than 60% so far this year. Cathie Wood has been adding shares of biotech company Ginkgo Bioworks ( DNA) to her exchange-traded funds (ETFs ...Ginkgo Bioworks (DNA 5.80%) ... A booming overall stock market is an important prerequisite for Ginkgo to have a chance of meeting Wall Street's expectations. The company could also potentially ...Ginkgo Bioworks Holdings Inc Stock (DNA) Forecast. The Ginkgo Bioworks Holdings Inc ( DNA) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $3.8461, representing a +163.43% increase from the current price of $1.46. The highest analyst price target is $7.2822, and the lowest is $0.4100.See the company profile for Ginkgo Bioworks Holdings, Inc. (DNA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...Cathie Wood, CEO of Ark Invest, has sunk an additional $600,000 into biotech firm Ginkgo Bioworks, buying into the stock’s recent dip. Ark purchased a total of 514,809 shares of Ginkgo Nov. 9 ...In connection with the Closing, the Company will change its name to Ginkgo Bioworks Holdings, Inc. and the combined company’s shares of Class A common stock and public warrants are expected to ...
On that note, on August 29 Ginkgo Bioworks ( DNA 5.80%) announced that it is joining forces with Alphabet, Google's parent company, in a five-year strategic partnership to develop and use new ...Aug 16, 2022 · Cutting-edge biotech company Ginkgo Bioworks Holdings ( DNA -4.79%) was a popular stock on Tuesday. The cell engineering specialist's share price zoomed more than 7% higher today, thanks to ... What this means: InvestorsObserver gives Ginkgo Bioworks Hldgs Inc (DNA) an overall rank of 43, which is below average. Ginkgo Bioworks Hldgs Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 43 means that 57% of stocks appear more favorable to our system.Dec 1, 2023 · Ginkgo Bioworks Holdings Aktie Profil. Die Ginkgo Bioworks Holdings Aktie wird unter der ISIN US37611X1000 an den Börsen Frankfurt, München, Berlin, New York, NYSE MKT, Bats, NYSE Bsc, Gettex ... Instagram:https://instagram. potential short squeeze stocksgoodyear targetwhy is tesla stock going downmsg sphere las vegas capacity Ginkgo Bioworks Holdings, Inc. (DNA) delivered earnings and revenue surprises of 11.11% and 30.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for ...Ginkgo Bioworks (NYSE:DNA) Is among the more prominent stocks in the synthetic biology space. The company is located in Boston, Massachusetts, which is a … se stock forecastwhat was the jobs report today Contact Us U.S. markets close in 28 minutes S&P 500 +26.05(+0.57%) Dow 30 +272.05(+0.76%) Nasdaq +74.18(+0.52%) Russell 2000 1,852.18 +43.16(+2.39%) Crude Oil 74.32 -1.64(-2.16%) Gold 2,089.10... will tesla stock go down tomorrow Some 400 Ginkgo Bioworks employees traveled to NYC to celebrate the company’s first day of trading on the NYSE. Many were now millionaires, while Ginkgo’s five founders’ stakes approached $1 ...May 11, 2021 · Synthetic biology pioneer Ginkgo Bioworks agreed to go public today in a $17.5 billion SPAC deal. The Boston-based company will merge with Soaring Eagle Acquisition Corp., a blank-check firm ... Ginkgo Bioworks ( DNA -7.19%) is a biotech that's operating on multiple bleeding edges of innovation as it works to engineer and manufacture biological cells at scale. Between its highly automated ...